d. Consensus development meeting
All stakeholders were invited to the meeting, which was attended by 24
participants in person, 6 participants virtually for the entire day, and
DM in person as an advisor. The provisional statement set tabulated
above was shared with the participants together with an initial draft of
this manuscript. At the meeting, held in Cairo, Egypt, on the
22nd February 2022, statements that were classified as
not having reached consensus in the two-round Delphi survey were
individually discussed. Stakeholders decided on the agreement rate to be
used as the threshold for exclusion and voted anonymously using an
electronic system (Zoom meeting software) to select statements for the
final set. The breakdown of statements into the various stages of the
RCT research lifecycle was agreed with the stakeholder group. This
included subheadings general, design and approval, conduct and
monitoring, reporting of protocols and findings, post-publication
concerns, and future research and development. In tabulation of the
final set, the strength of evidence assessed via a modified AMSTAR-2
score26 was provided for the statements underpinned by
systematic reviews.